Central zone of myocardial infarction: A neglected target area for heart cell therapy

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 3, 2012, Pages 636-647

  Jin, Peifeng ^a,b   Wang, Enshi ^a   Wang, Ye Huan ^b,c   Huang, Weicong ^b   Kuang, Wenan ^b   Sun, Chengchao ^b   Hu, Shengshou ^a   Zhang, Hao ^a  

^a FUWAI HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c Department of Emergency   (China)

Author keywords

Apoptosis; Cell therapy; Cell transplantation; Mesenchymal stem cells; Myocardial infarction; Ventricular remodelling

Indexed keywords

RATTUS;

EID: 84863172008     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01408.x     Document Type: Article

References (27)

1. Nesselmann C, Ma N, Bieback K, et al. Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008; 12: 1795-810.
2. van Oorschot AA, Smits AM, Pardali E, et al. Low oxygen tension positively influences cardiomyocyte progenitor cell function. J Cell Mol Med. 2011; doi: 10.1111/j.1582-4934.2011.01270.x.
3. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
4. Jackson BM, Gorman JH, Moainie SL, et al. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol. 2002; 40: 1160-7; discussion 8-71.
5. Hou M, Yang KM, Zhang H, et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol. 2007; 115: 220-8.
6. Su W, Zhang H, Jia Z, et al. Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium?Stem Cells. 2006; 24: 349-56.
7. Palojoki E, Saraste A, Eriksson A, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol. 2001; 280: H2726-31.
8. Zhang H, Zhu SJ, Wang W, et al. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 2008; 15: 40-8.
9. Zhang H, Zhu SJ, Wang D, et al. Intramyocardial injection of tannic acid attenuates postinfarction remodeling: a novel approach to stabilize the breaking extracellular matrix. J Thorac Cardiovasc Surg. 2009; 137: 216-22, 22e1-2.
10. Zhang H, Hou JF, Shen Y, et al. Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. J Cell Mol Med. 2010; 14: 1975-87.
11. Liu X, Hou J, Shi L, et al. Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells Dev. 2009; 18: 947-54.
12. Wang W, Jiang Q, Zhang H, et al. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen Med. 2011; 6: 179-90.
13. Xin Y, Wang YM, Zhang H, et al. Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs. 2010; 34: 215-22.
14. Zhang H, Chen H, Wang W, et al. Cell survival and redistribution after transplantation into damaged myocardium. J Cell Mol Med. 2010; 14: 1078-82.
15. Wang W, Jin P, Wang L, et al. Impact of escaped bone marrow mesenchymal stromal cells on extracardiac organs after intramyocardial implantation in a rat myocardial infarction model. Cell Transplant. 2010; 19: 1599-607.
16. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001; 33: 907-21.
17. Muller-Ehmsen J, Whittaker P, Kloner RA, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002; 34: 107-16.
18. Castagnino HE, Toranzos FA, Milei J, et al. Preservation of the myocardial collagen framework by human growth hormone in experimental infarctions and reduction in the incidence of ventricular aneurysms. Int J Cardiol. 1992; 35: 101-14.
19. Dixon JA, Gorman RC, Stroud RE, et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation. 2009; 120: S220-9.
20. Li X, Yu X, Lin Q, et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol. 2007; 42: 295-303.
21. Kinnaird T, Stabile E, Burnett MS, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004; 109: 1543-9.
22. Tang YL, Zhao Q, Qin X, et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg. 2005; 80: 229-36.
23. Timmers L, Lim SK, Hoefer IE, et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 2011; 6: 206-14.
24. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
25. Popescu LM Telocytes-a novel type of interstitial cells. In: Braisant OHWH, Kang I, Allegaert K, et al., editors. Recent researches in modern medicine - HISTEM'11. Cambridge: WSEAS Press; 2011. p. 424-32.
26. Popescu LM, Gherghiceanu M, Manole CG, et al. Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med. 2009; 13: 866-86.
27. Popescu LM Telocytes and stem cells: a tandem in cardiac regenerative medicine. Curr Med Chem. 2011; 18: 94.